Valéry Attignon

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Validated predictive biomarkers for multi-tyrosine kinase inhibitors (MTKI) efficacy are lacking. We hypothesized that interindividual response variability is partially dependent on somatic DNA copy number alterations (SCNAs), particularly those of genes encoding the protein tyrosines targeted by MTKI (called target genes). Genomic alterations were(More)
  • 1